Rapid phenotypic methods to improve the diagnosis of bacterial bloodstream infections: meeting the challenge to reduce the time to result.
G Dubourg, B Lamy, R Ruimy
https://pubmed.ncbi.nlm.nih.gov/29605563/Actively Recruiting
Led by University Hospital, Grenoble · Updated on 2026-07-22
200
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are investigating a new way to identify bacteria that cause bloodstream infections, specifically bacteremia. The study focuses on improving the early stages of the blood culture process, from collecting blood to detecting bacterial growth in culture bottles. By using machine learning to analyze the electrochemical signals of bacteria as they grow, the study aims to speed up pathogen identification and provide quicker, useful results for treating infections. Participants will have blood samples taken as part of their standard care. In addition to the usual blood culture bottle, two to four extra bottles will be collected and spiked with known bacteria to create an electrochemical profile database. This process will help develop a system that can recognize bacteria based on their electrical signals while still inside the culture bottle. During the study, researchers will monitor these blood culture bottles, measuring their electrochemical fingerprints up to one week after sampling. The main outcome is to collect a list of these profiles. The study will also assess how well the identification method works by the end of the research period. The total participation duration is linked to the time needed for these electrochemical measurements and performance evaluations.
CONDITIONS
Machine Learning Assisted Electrochemical Profiling to Provide Early Identification of Bloodstream Infections Pathogens
Y
Yvan CASPAR, PharmD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital, Grenoble
Lead Sponsor
CEA - Leti
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening visit
Duration - Up to 1 week after blood sampling
Participants will have standard blood culture samples collected along with 2 to 4 additional blood culture bottles for testing. These bottles will be monitored to measure bacterial electrochemical profiles.
1 visit for blood collection; monitoring occurs during this period
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
G Dubourg, B Lamy, R Ruimy
https://pubmed.ncbi.nlm.nih.gov/29605563/Brigitte Lamy, Martin Sundqvist, Evgeny A Idelevich...
https://pubmed.ncbi.nlm.nih.gov/31760113/University Hospital, Grenoble
Lead Sponsor
CEA - Leti
Collaborating Sponsor